Breaking News

Sanofi Invests in Cutting Edge Vax Production Site in Singapore

The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi will invest €400 million over five years to create a new vaccine production site in Singapore leveraging cutting edge manufacturing and digital technologies. The new site will allow Sanofi to produce innovative vaccines on a massive scale for Asia, and quickly respond to future pandemic risks.   The Singapore site complements Sanofi’s existing manufacturing capacities in Europe and North America and will become a regional center of excellence for vaccines production in Asia.   The pro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters